Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Disialoganglioside GD2 inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Multiple Myeloma | 1 | D009101 | ClinicalTrials |
| Mesothelioma | 1 | D008654 | ClinicalTrials |
| Small Cell Lung Carcinoma | 1 | D055752 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109426 |
CONTENTS